PANCREAS ISLET CELL TRANSPLANT

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting PANCREAS ISLET CELL TRANSPLANT:

# Drug Count
0 PANCRELIPASE 11
1 INSULIN LISPRO 4
2 INSULIN ASPART 2
3 INSULIN GLARGINE 2
4 SODIUM OXYBATE 2
5 ABATACEPT 1
6 BETAINE 1
7 CLOPIDOGREL 1
8 ETANERCEPT 1
9 INSULIN HUMAN 1
See all common drugs associated with PANCREAS ISLET CELL TRANSPLANT

PANCREAS ISLET CELL TRANSPLANT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BETAINE 1 0.0010
1 PANCRELIPASE 11 0.0003
2 SODIUM OXYBATE 2 0.0000
3 INSULIN ASPART 2 0.0000
4 INSULIN LISPRO 4 0.0000
5 INSULIN HUMAN 1 0.0000
6 INSULIN GLARGINE 2 0.0000
7 ABATACEPT 1 0.0000
8 TACROLIMUS 1 0.0000
9 CLOPIDOGREL 1 0.0000
See all drugs enriched for association with PANCREAS ISLET CELL TRANSPLANT

These drug classes are most commonly taken by patients reporting PANCREAS ISLET CELL TRANSPLANT:

# Drug class Count
0 Insulin Analog [EPC] 6
1 Insulin [EPC] 1
2 Methylating Agent [EPC] 1
3 Selective T Cell Costimulation Modulator [EPC] 1
4 Tumor Necrosis Factor Blocker [EPC] 1
See all common drug classes associated with PANCREAS ISLET CELL TRANSPLANT

PANCREAS ISLET CELL TRANSPLANT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Methylating Agent [EPC] 1 0.0010
1 Insulin [EPC] 1 0.0000
2 Insulin Analog [EPC] 6 0.0000
3 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
4 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
See all drug classes enriched for association with PANCREAS ISLET CELL TRANSPLANT